The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: A concordance and validation study

被引:85
作者
Ballardini, B. [1 ]
Santoro, L. [2 ]
Sangalli, C. [1 ]
Gentilini, O. [1 ]
Renne, G. [4 ]
Lissidini, G. [1 ]
Pagani, G. M. [1 ]
Toesca, A. [1 ]
Blundo, C. [1 ]
del Castillo, A. [1 ]
Peradze, N. [1 ]
Caldarella, P. [1 ]
Veronesi, P. [1 ,3 ]
机构
[1] European Inst Oncol, Div Breast Surg, I-20141 Milan, Italy
[2] European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy
[3] Univ Milan, Sch Med, Milan, Italy
[4] European Inst Oncol, Div Pathol, I-20141 Milan, Italy
来源
EJSO | 2013年 / 39卷 / 12期
关键词
Breast cancer sentinel node biopsy; Sentinel node identification; Indocyanine green; Radio-labeled colloid; BLUE-DYE; BIOPSY; FLUORESCENCE; LYMPHOSCINTIGRAPHY;
D O I
10.1016/j.ejso.2013.10.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The aim of this study was to assess concordance between the indocyanine green (ICG) method and Tc-99m-radiotracer method to identify the sentinel node (SN) in breast cancer. Evidence supports the feasibility and efficacy of the ICG to identify the SN, however this method has not been prospectively compared with the gold-standard radiotracer method in terms of SN detection rate. Methods: Between June 2011 and January 2013, 134 women with clinically node-negative early breast cancer received subdermal/peritumoral injection of Tc-99m-labeled tracer for lymphoscintigraphy, followed by intraoperative injection of ICG for fluorescence detection of SNs using an exciting light source combined with a camera. In all patients, SNs were first identified by the fluorescence method (ICG-positive) and removed. A gamma ray-detecting probe was then used to determine whether ICG-positive SNs were hot (Tc-99m-positive) and to identify and remove any Tc-99m-positive (ICG-negative) SNs remaining in the axilla. The study was powered to perform an equivalence analysis. Results: The 134 patients provided 246 SNs, detected by one or both methods. 1, 2 and 3 SNs, respectively, were detected, removed and examined in 70 (52.2%), 39 (29.1%) and 17 (12.7%) patients; 4-10 SNs were detected and examined in the remaining 8 patients. The two methods were concordant for 230/246 (93.5%) SNs and discordant for 16 (6.5%) SNs. The ICG method detected 99.6% of all SNs. Conclusions: Fluorescent lymphangiography with ICG allows easy identification of axillary SNs, at a frequency not inferior to that of radiotracer, and can be used alone to reliably identify SNs. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1332 / 1336
页数:5
相关论文
共 29 条
[11]   Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer [J].
Kitai T. ;
Inomoto T. ;
Miwa M. ;
Shikayama T. .
Breast Cancer, 2005, 12 (3) :211-215
[12]   Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer [J].
Kitai, Toshiyuki ;
Kawashima, Masahiro .
BREAST CANCER, 2012, 19 (04) :343-348
[13]   Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial [J].
Krag, David N. ;
Anderson, Stewart J. ;
Julian, Thomas B. ;
Brown, Ann M. ;
Harlow, Seth P. ;
Costantino, Joseph P. ;
Ashikaga, Takamaru ;
Weaver, Donald L. ;
Mamounas, Eleftherios P. ;
Jalovec, Lynne M. ;
Frazier, Thomas G. ;
Noyes, R. Dirk ;
Robidoux, Andre ;
Scarth, Hugh M. C. ;
Wolmark, Norman .
LANCET ONCOLOGY, 2010, 11 (10) :927-933
[14]   ON THE SAMPLE-SIZE FOR ONE-SIDED EQUIVALENCE OF SENSITIVITIES BASED UPON MCNEMARS TEST [J].
LU, Y ;
BEAN, JA .
STATISTICS IN MEDICINE, 1995, 14 (16) :1831-1839
[15]   Interval estimation of generalized odds ratio in data with repeated measurements [J].
Lui, KJ .
STATISTICS IN MEDICINE, 2002, 21 (20) :3107-3117
[16]   American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer [J].
Lyman, GH ;
Giuliano, AE ;
Somerfield, MR ;
Benson, AB ;
Bodurka, DC ;
Burstein, HJ ;
Benson, AB ;
Bodurka, DC ;
Burstein, HJ ;
Cochran, AJ ;
Cody, HS ;
Edge, SB ;
Galper, S ;
Hayman, JA ;
Kim, TY ;
Perkins, CL ;
Podoloff, DA ;
Sivasubramaniam, VH ;
Turner, RR ;
Wahl, R ;
Weaver, DL ;
Wolff, AC ;
Winer, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7703-7720
[17]   Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer [J].
Mieog, J. Sven D. ;
Troyan, Susan L. ;
Hutteman, Merlijn ;
Donohoe, Kevin J. ;
van der Vorst, Joost R. ;
Stockdale, Alan ;
Liefers, Gerrit-Jan ;
Choi, Hak Soo ;
Gibbs-Strauss, Summer L. ;
Putter, Hein ;
Gioux, Sylvain ;
Kuppen, Peter J. K. ;
Ashitate, Yoshitomo ;
Lowik, Clemens W. G. M. ;
Smit, Vincent T. H. B. M. ;
Oketokoun, Rafiou ;
Ngo, Long H. ;
van de Velde, Cornelis J. H. ;
Frangioni, John V. ;
Vahrmeijer, Alexander L. .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (09) :2483-2491
[18]   Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence [J].
Murawa, D. ;
Hirche, C. ;
Dresel, S. ;
Huenerbein, M. .
BRITISH JOURNAL OF SURGERY, 2009, 96 (11) :1289-1294
[19]   Comparison of validity of assessment methods using indices of adjusted agreement [J].
Nam, Jun-mo .
STATISTICS IN MEDICINE, 2007, 26 (03) :620-632
[20]  
Paganelli G, 1998, Q J NUCL MED, V42, P49